A-share subscription | FENGBEI BIOTECH starts subscription with existing biodiesel production capacity of 105,000 tons

FENGBEI BIOTECH started its subscription on October 27, with an issue price of 24.49 yuan per share, a subscription limit of 11,000 shares, and a price-to-earnings ratio of 30.47 times. The company focuses on the comprehensive utilization of waste oil resources, with an existing biodiesel production capacity of 105,000 tons, ranking sixth in the industry. From 2022 to 2024, the company's operating revenues are projected to be 1.709 billion yuan, 1.728 billion yuan, and 1.948 billion yuan, with net profits of 133 million yuan, 130 million yuan, and 124 million yuan, respectively. The net cash flow from operating activities is expected to decline in 2024